High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity
Author:
Funder
CNPq
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00109-022-02185-4.pdf
Reference100 articles.
1. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel M et al (2020) The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. https://doi.org/10.1007/s11481-020-09944-5
2. WHO. World Health Organization (2021) WHO coronavirus disease (COVID-19) dashboard. Available at: https://covid19.who.int/. Accessed 29 Aug 2021
3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
4. Hartung H-P, Aktas O (2020) COVID-19 and management of neuroimmunological disorders. Nat Rev Neurol 16:347–348. https://doi.org/10.1038/s41582-020-0368-9
5. Berlin DA, Gulick RM, Martinez FJ (2020) Severe COVID-19. N Engl J Med. https://doi.org/10.1056/NEJMcp2009575
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit;Cytokine;2024-03
2. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome;Frontiers in Immunology;2024-01-18
3. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19;International Journal of Molecular Sciences;2023-12-18
4. Tollip deficiency exaggerates airway type 2 inflammation in mice exposed to allergen and influenza A virus: role of the ATP/IL-33 signaling axis;Frontiers in Immunology;2023-12-06
5. Purinergic signaling in the battlefield of viral infections;Purinergic Signalling;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3